Fibroblast growth factors (FGFs) and their surface receptors (FGFRs) are critical components of many important biological processes including bone development. The four known FGFRs (FGFR1-FGFR4) are receptor tyrosine kinases (RTKs) activated by binding FGFs and heparin or heparan sulfate proteoglycans to their extracellular ligand binding domain resulting in FGFR dimerization and protein tyrosine kinase activation. It has been shown that the docking protein FRS2 plays a major role in mediating the intracellular signaling pathways following FGF stimulation. Other proteins implicated in FGF signaling include Shc, Gab1, Shp2 and Stat1 among others. Gene inactivation experiments in mice have shown that FGFR2 and FGFR3 play an important role in bone development. Moreover, mutations primarily in Fgfr2 and Fgfr3 were shown to be responsible for a variety of bone and skeletal disorders including Crouzon, Apert, Jackson- Weiss, achondroplasia and thanatophoric dysplasia syndromes. The goal of this proposal is to obtain a comprehensive view of the intracellular signaling pathways that are responsible for mediating bone development in response to FGFR2 and FGFR3 activation.
The specific aims of this proposal are to: (1) investigate the specific roles of the Fgfr3b and Fgfr3c isoforms in bone development by creating isoform specific knock-out mice, (2) develop genetically modified mice to explore the biological role of the docking protein FRS2 in Fgfr2c mediated bone development, (3) determine the role of FRS2 in human Icraniosynostosis syndrome using murine models, (4) identify FRS2 dependent and independent signaling Ipathways downstream of FGFR2 and FGFR3, and (5) determine the role of the SH2 domain containing IProtein 3BP2 in signaling via FGFR2 and FGFR3. Mutations in 3BP2 were found in cherubism, an lautosomal dominant inherited syndrome characterized by excessive bone degradation. Our goals will be accomplished by applying genetic, biochemical, structural and cell biological approaches. The information obtained from these studies will provide a detailed molecular view of how FGF signaling mediated by FGFR2 and FGFR3 and the docking protein FRS2 control bone development. It will also provide a framework for understanding diseases caused by mutations in FGFRs enabling the design of novel treatments for skeletal disorders such as craniosynostosis, achondroplasia, hypochondroplasia and thanatophoric dysplasia. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR051886-02
Application #
6997871
Study Section
Skeletal Biology Development and Disease Study Section (SBDD)
Program Officer
Wang, Fei
Project Start
2004-12-17
Project End
2009-11-30
Budget Start
2005-12-01
Budget End
2006-11-30
Support Year
2
Fiscal Year
2006
Total Cost
$343,976
Indirect Cost
Name
Yale University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Opatowsky, Yarden; Lax, Irit; Tomé, Francisco et al. (2014) Structure, domain organization, and different conformational states of stem cell factor-induced intact KIT dimers. Proc Natl Acad Sci U S A 111:1772-7
Shen, Hongying; Ferguson, Shawn M; Dephoure, Noah et al. (2011) Constitutive activated Cdc42-associated kinase (Ack) phosphorylation at arrested endocytic clathrin-coated pits of cells that lack dynamin. Mol Biol Cell 22:493-502
Ekkati, Anil R; Madiyan, Valsan; Ravindranathan, Krishna P et al. (2011) Aryl Extensions of Thienopyrimidinones as Fibroblast Growth Factor Receptor 1 Kinase Inhibitors. Tetrahedron Lett 52:2228-2231
Chung, Inhee; Akita, Robert; Vandlen, Richard et al. (2010) Spatial control of EGF receptor activation by reversible dimerization on living cells. Nature 464:783-7
Lemmon, Mark A; Schlessinger, Joseph (2010) Cell signaling by receptor tyrosine kinases. Cell 141:1117-34
Ravindranathan, Krishna P; Mandiyan, Valsan; Ekkati, Anil R et al. (2010) Discovery of novel fibroblast growth factor receptor 1 kinase inhibitors by structure-based virtual screening. J Med Chem 53:1662-72
Murohashi, Michiko; Nakamura, Takahisa; Tanaka, Satoshi et al. (2010) An FGF4-FRS2alpha-Cdx2 axis in trophoblast stem cells induces Bmp4 to regulate proper growth of early mouse embryos. Stem Cells 28:113-21
Bae, Jae Hyun; Boggon, Titus J; Tomé, Francisco et al. (2010) Asymmetric receptor contact is required for tyrosine autophosphorylation of fibroblast growth factor receptor in living cells. Proc Natl Acad Sci U S A 107:2866-71
Yang, Yan; Xie, Peng; Opatowsky, Yarden et al. (2010) Direct contacts between extracellular membrane-proximal domains are required for VEGF receptor activation and cell signaling. Proc Natl Acad Sci U S A 107:1906-11
Lew, Erin D; Furdui, Cristina M; Anderson, Karen S et al. (2009) The precise sequence of FGF receptor autophosphorylation is kinetically driven and is disrupted by oncogenic mutations. Sci Signal 2:ra6

Showing the most recent 10 out of 31 publications